SCHEMBL20142357

SCHEMBL20142357

N#Cc1ccc(C(=O)c2sc(Nc3ccccc3)nc2N)cc1

nearest known ligand 0.79

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.79
GSK3B P49841 2/20 0.79
CCNA2 P20248 11/20 0.77
CDK2 P24941 11/20 0.77
CDK5 Q00535 6/20 0.77
CDK5R1 Q15078 6/20 0.77
MAPT P10636 3/20 0.77
NPC1 O15118 2/20 0.77
RAB9A P51151 1/20 0.77
MAPK14 Q16539 1/20 0.77
TDP1 Q9NUW8 1/20 0.77
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
LMNA P02545 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25609556 0.95 GSK3A (0.79) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142463 0.94 GSK3A (0.89) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142196 0.92 GSK3A (0.81) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142449 0.88 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142290 0.88 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20141891 0.88 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20141893 0.88 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142068 0.88 GSK3A (1.00) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL20142458 0.88 GSK3A (0.80) GSK3AGSK3BCCNA2CDK2CDK5
SCHEMBL1248419 0.87 CCNA2 (1.00) GSK3AGSK3BCCNA2CDK2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO claimed
WO-2018089902-A1 DIAMINOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE APOGEE BIOTECHNOLOGY CORPORATION (US) 2018-05-17 WO disclosed